Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Inhaled Tissue Plasminogen Activator (tPA) for the Acute Treatment of Pediatric Plastic Bronchitis

NCT02315898 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT02315898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02315898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Inhaled Tissue Plasminogen Activator (tPA) for the Acute Treatment of Pediatric Plastic Bronchitis
Lead sponsor
University of Michigan
Phase
Phase 2
Overall status
Completed
Start date
March 19, 2018
Completion date
June 30, 2023
Enrollment
40 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, plastic bronchitis, protein-losing enteropathies